10/25/2024 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $65.00 ➝ $75.00 | |
10/22/2024 | Oppenheimer | Boost Target | Outperform ➝ Outperform | $65.00 ➝ $85.00 | |
10/8/2024 | JMP Securities | Reiterated Rating | Market Outperform ➝ Market Outperform | $110.00 ➝ $110.00 | |
8/27/2024 | Sanford C. Bernstein | Boost Target | Market Perform ➝ Market Perform | $68.00 ➝ $70.00 | |
8/23/2024 | Tigress Financial | Boost Target | Buy ➝ Buy | $75.00 ➝ $85.00 | |
8/5/2024 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $70.00 ➝ $65.00 | |
8/2/2024 | JPMorgan Chase & Co. | Boost Target | Overweight ➝ Overweight | $76.00 ➝ $78.00 | |
8/2/2024 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $60.00 ➝ $65.00 | |
8/2/2024 | Piper Sandler | Reiterated Rating | Overweight ➝ Overweight | $77.00 ➝ $83.00 | |
7/10/2024 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $79.00 ➝ $77.00 | |
6/28/2024 | Tigress Financial | Initiated Coverage | Buy | $75.00 | |
6/14/2024 | Morgan Stanley | Downgrade | Overweight ➝ Equal Weight | $70.00 ➝ $60.00 | |
5/20/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $71.00 | |
5/8/2024 | Macquarie | Lower Target | Neutral ➝ Neutral | $69.00 ➝ $63.00 | |
5/8/2024 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $90.00 ➝ $85.00 | |
5/8/2024 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $78.00 ➝ $79.00 | |
5/8/2024 | Sanford C. Bernstein | Lower Target | Market Perform ➝ Market Perform | $70.00 ➝ $68.00 | |
5/8/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $71.00 | |
5/8/2024 | Robert W. Baird | Lower Target | Neutral ➝ Neutral | $70.00 ➝ $65.00 | |
4/17/2024 | Oppenheimer | Reiterated Rating | Outperform ➝ Outperform | $75.00 | |
3/6/2024 | UBS Group | Lower Target | Buy ➝ Buy | $82.00 ➝ $74.00 | |
3/6/2024 | TD Cowen | Lower Target | Market Perform ➝ Market Perform | $72.00 ➝ $65.00 | |
3/6/2024 | Stifel Nicolaus | Lower Target | Hold ➝ Hold | $70.00 ➝ $60.00 | |
3/6/2024 | Royal Bank of Canada | Reiterated Rating | Underperform ➝ Underperform | $50.00 | |
3/6/2024 | The Goldman Sachs Group | Boost Target | Neutral ➝ Neutral | $69.00 ➝ $70.00 | |
3/6/2024 | Jefferies Financial Group | Lower Target | Hold ➝ Hold | $65.00 ➝ $60.00 | |
3/6/2024 | Wells Fargo & Company | Lower Target | Equal Weight ➝ Equal Weight | $70.00 ➝ $60.00 | |
2/15/2024 | JMP Securities | Reiterated Rating | Market Outperform ➝ Market Outperform | $110.00 | |
2/15/2024 | Royal Bank of Canada | Reiterated Rating | Underperform ➝ Underperform | $50.00 | |
2/15/2024 | Robert W. Baird | Boost Target | Neutral ➝ Neutral | $65.00 ➝ $70.00 | |
2/15/2024 | Northland Securities | Downgrade | Outperform ➝ Market Perform | $66.00 | |
2/14/2024 | HSBC | Downgrade | Hold ➝ Reduce | $62.00 ➝ $61.00 | |
1/24/2024 | Barclays | Boost Target | Equal Weight ➝ Equal Weight | $60.00 ➝ $70.00 | |
1/12/2024 | Piper Sandler | Upgrade | Neutral ➝ Overweight | $75.00 ➝ $82.00 | |
1/9/2024 | The Goldman Sachs Group | Boost Target | Neutral ➝ Neutral | $63.00 ➝ $72.00 | |
12/13/2023 | Needham & Company LLC | Boost Target | Buy ➝ Buy | $70.00 ➝ $80.00 | |
12/5/2023 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $70.00 | |
12/5/2023 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $60.00 ➝ $70.00 | |
11/9/2023 | William Blair | Reiterated Rating | Outperform | | |
11/9/2023 | Piper Sandler | Boost Target | Neutral ➝ Neutral | $68.00 ➝ $69.00 | |
11/9/2023 | JMP Securities | Reiterated Rating | Market Outperform ➝ Market Outperform | $110.00 | |
11/9/2023 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $55.00 ➝ $60.00 | |
11/9/2023 | Needham & Company LLC | Lower Target | Buy ➝ Buy | $75.00 ➝ $70.00 | |
9/15/2023 | HSBC | Initiated Coverage | Hold | $67.00 | |
8/25/2023 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $75.00 | |
8/11/2023 | Jefferies Financial Group | Boost Target | | $50.00 ➝ $55.00 | |
8/11/2023 | Argus | Upgrade | Hold ➝ Buy | $72.00 | |
8/10/2023 | Northland Securities | Boost Target | Outperform ➝ Outperform | $60.00 ➝ $66.00 | |
8/9/2023 | Needham & Company LLC | Boost Target | Buy ➝ Buy | $65.00 ➝ $75.00 | |
8/9/2023 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $60.00 ➝ $65.00 | |
8/9/2023 | The Goldman Sachs Group | Boost Target | Neutral ➝ Neutral | $53.00 ➝ $67.00 | |
8/9/2023 | UBS Group | Boost Target | Buy ➝ Buy | $65.00 ➝ $73.00 | |
8/9/2023 | Piper Sandler | Lower Target | | $71.00 ➝ $68.00 | |
8/9/2023 | Sanford C. Bernstein | Boost Target | | $58.00 ➝ $68.00 | |
8/9/2023 | Barclays | Boost Target | Equal Weight ➝ Equal Weight | $50.00 ➝ $60.00 | |
7/24/2023 | Royal Bank of Canada | Downgrade | Sector Perform ➝ Underperform | $55.00 ➝ $50.00 | |
7/19/2023 | Morgan Stanley | Boost Target | Overweight | $65.00 ➝ $75.00 | |
7/17/2023 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $56.00 ➝ $71.00 | |
5/12/2023 | Robert W. Baird | Lower Target | | $80.00 ➝ $56.00 | |
5/12/2023 | Mizuho | Downgrade | Buy ➝ Neutral | $90.00 ➝ $55.00 | |
5/11/2023 | Barclays | Lower Target | | $75.00 ➝ $50.00 | |
5/11/2023 | The Goldman Sachs Group | Downgrade | Buy ➝ Neutral | $90.00 ➝ $53.00 | |
5/10/2023 | Stifel Nicolaus | Lower Target | | $75.00 ➝ $50.00 | |
5/10/2023 | Royal Bank of Canada | Lower Target | | $75.00 ➝ $55.00 | |
5/10/2023 | Oppenheimer | Lower Target | | $85.00 ➝ $75.00 | |
5/10/2023 | Bank of America | Lower Target | | $65.00 ➝ $55.00 | |
5/10/2023 | Morgan Stanley | Lower Target | | $82.00 ➝ $65.00 | |
5/10/2023 | Sanford C. Bernstein | Lower Target | | $77.00 ➝ $58.00 | |
5/10/2023 | Piper Sandler | Lower Target | | $83.00 ➝ $56.00 | |
5/3/2023 | UBS Group | Lower Target | | $93.00 ➝ $85.00 | |
2/24/2023 | Jefferies Financial Group | Boost Target | | $50.00 ➝ $60.00 | |
2/21/2023 | Mizuho | Boost Target | Buy | $75.00 ➝ $90.00 | |
2/16/2023 | Needham & Company LLC | Boost Target | Buy | $60.00 ➝ $88.00 | |
2/16/2023 | Canaccord Genuity Group | Boost Target | Buy | $88.00 ➝ $97.00 | |
2/16/2023 | UBS Group | Boost Target | Buy | $77.00 ➝ $93.00 | |
2/16/2023 | Piper Sandler | Boost Target | Overweight | $69.00 ➝ $83.00 | |
2/16/2023 | Royal Bank of Canada | Boost Target | Sector Perform | $55.00 ➝ $75.00 | |
2/16/2023 | Cowen | Boost Target | Market Perform | $65.00 ➝ $75.00 | |
2/16/2023 | Wells Fargo & Company | Boost Target | Equal Weight | $60.00 ➝ $70.00 | |
2/16/2023 | Morgan Stanley | Boost Target | Overweight | $64.00 ➝ $82.00 | |
2/16/2023 | Robert W. Baird | Boost Target | Neutral | $55.00 ➝ $80.00 | |
2/16/2023 | Sanford C. Bernstein | Boost Target | Market Perform | $58.00 ➝ $77.00 | |
2/16/2023 | KeyCorp | Boost Target | Overweight | $77.00 ➝ $89.00 | |
2/13/2023 | Stifel Nicolaus | Boost Target | | $45.00 ➝ $60.00 | |
1/17/2023 | Piper Sandler | Lower Target | | $79.00 ➝ $69.00 | |
1/3/2023 | Oppenheimer | Lower Target | | $110.00 ➝ $75.00 | |
12/14/2022 | Morgan Stanley | Lower Target | Overweight | $70.00 ➝ $64.00 | |
11/27/2022 | Jefferies Financial Group | Downgrade | Buy ➝ Hold | $110.00 ➝ $50.00 | |
11/7/2022 | Morgan Stanley | Lower Target | Overweight | $100.00 ➝ $70.00 | |
11/7/2022 | The Goldman Sachs Group | Lower Target | Buy | $132.00 ➝ $80.00 | |
11/7/2022 | KeyCorp | Lower Target | Overweight | $96.00 ➝ $77.00 | |
11/6/2022 | Barclays | Lower Target | Equal Weight | $90.00 ➝ $60.00 | |
11/4/2022 | JMP Securities | Lower Target | Market Outperform | $175.00 ➝ $110.00 | |
11/4/2022 | BTIG Research | Downgrade | Buy ➝ Neutral | | |
11/4/2022 | Canaccord Genuity Group | Lower Target | | $153.00 ➝ $88.00 | |
11/4/2022 | Oppenheimer | Lower Target | | $170.00 ➝ $110.00 | |
11/4/2022 | Cowen | Downgrade | Outperform ➝ Market Perform | $100.00 ➝ $65.00 | |
11/4/2022 | Bank of America | Lower Target | | $85.00 ➝ $70.00 | |
11/4/2022 | Wells Fargo & Company | Downgrade | Overweight ➝ Equal Weight | $140.00 ➝ $60.00 | |
11/4/2022 | Mizuho | Lower Target | Buy | $125.00 ➝ $75.00 | |
11/4/2022 | Cowen | Downgrade | Outperform ➝ Market Perform | $100.00 ➝ $65.00 | |
11/4/2022 | Royal Bank of Canada | Downgrade | Outperform ➝ Sector Perform | $110.00 ➝ $55.00 | |
11/4/2022 | Piper Sandler | Lower Target | Overweight | $113.00 ➝ $79.00 | |
11/2/2022 | Bank Of America (Bofa) | Downgrade | Underperform | $85.00 | |
11/2/2022 | Bank of America | Downgrade | Buy ➝ Underperform | $175.00 ➝ $85.00 | |
10/19/2022 | Cowen | Lower Target | Outperform | $125.00 ➝ $100.00 | |
10/19/2022 | Cowen | Lower Target | Outperform | $125.00 ➝ $100.00 | |
10/19/2022 | UBS Group | Lower Target | Buy | $170.00 ➝ $94.00 | |
10/11/2022 | Morgan Stanley | Lower Target | Overweight | $160.00 ➝ $100.00 | |
9/26/2022 | Piper Sandler | Lower Target | Overweight | $122.00 ➝ $113.00 | |
9/23/2022 | Credit Suisse Group | Initiated Coverage | Neutral | $80.00 | |
9/15/2022 | Stifel Nicolaus | Lower Target | Hold | $90.00 ➝ $80.00 | |
9/15/2022 | BTIG Research | Lower Target | Buy | $130.00 ➝ $105.00 | |
9/12/2022 | KeyCorp | Initiated Coverage | Overweight | $96.00 | |
8/15/2022 | Barclays | Lower Target | | $90.00 | |
8/10/2022 | Argus | Downgrade | Buy ➝ Hold | | |
8/9/2022 | BTIG Research | Lower Target | | $130.00 | |
8/9/2022 | Barclays | Lower Target | | $90.00 | |
8/8/2022 | The Goldman Sachs Group | Lower Target | Buy | $180.00 ➝ $155.00 | |
8/8/2022 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $245.00 ➝ $153.00 | |
8/5/2022 | Cowen | Lower Target | | $150.00 ➝ $125.00 | |
8/5/2022 | Cowen | Lower Target | | $150.00 ➝ $125.00 | |
8/5/2022 | Canaccord Genuity Group | Lower Target | Buy | $245.00 ➝ $153.00 | |
8/5/2022 | Mizuho | Lower Target | Buy | $200.00 ➝ $125.00 | |
8/5/2022 | Oppenheimer | Lower Target | Outperform | $260.00 ➝ $210.00 | |
8/5/2022 | Atlantic Securities | Downgrade | Overweight ➝ Neutral | $240.00 ➝ $100.00 | |
8/5/2022 | Piper Sandler | Lower Target | Overweight | $132.00 ➝ $122.00 | |
8/5/2022 | Stifel Nicolaus | Downgrade | Buy ➝ Hold | $200.00 ➝ $90.00 | |
7/25/2022 | Macquarie | Downgrade | Outperform ➝ Neutral | $96.00 | |
7/22/2022 | Cowen | Lower Target | Outperform | $250.00 ➝ $150.00 | |
7/19/2022 | Sanford C. Bernstein | Initiated Coverage | Market Perform | $91.00 | |
7/18/2022 | Piper Sandler | Lower Target | Overweight | $220.00 ➝ $132.00 | |
7/14/2022 | Morgan Stanley | Lower Target | Overweight | $240.00 ➝ $160.00 | |
6/8/2022 | Scotiabank | Initiated Coverage | Outperform | $215.00 | |
6/2/2022 | Barclays | Downgrade | Overweight ➝ Equal Weight | $175.00 ➝ $110.00 | |
5/23/2022 | Jefferies Financial Group | Lower Target | | $175.00 ➝ $130.00 | |
5/18/2022 | Wells Fargo & Company | Lower Target | Overweight | $225.00 ➝ $180.00 | |
5/16/2022 | Robert W. Baird | Downgrade | Outperform ➝ Neutral | $155.00 ➝ $120.00 | |
5/9/2022 | Mizuho | Lower Target | | $300.00 ➝ $200.00 | |
5/5/2022 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $455.00 ➝ $245.00 | |
5/5/2022 | Cowen | Lower Target | | $300.00 ➝ $250.00 | |
5/5/2022 | BTIG Research | Lower Target | | $270.00 ➝ $230.00 | |
5/5/2022 | JMP Securities | Lower Target | | $510.00 ➝ $250.00 | |
5/5/2022 | Needham & Company LLC | Lower Target | | $350.00 ➝ $200.00 | |
5/5/2022 | Cowen | Lower Target | | $300.00 ➝ $250.00 | |
5/5/2022 | Oppenheimer | Lower Target | | $380.00 ➝ $320.00 | |
5/3/2022 | Wells Fargo & Company | Lower Target | | $285.00 ➝ $225.00 | |
5/3/2022 | Royal Bank of Canada | Lower Target | | $400.00 ➝ $200.00 | |
4/21/2022 | Cowen | Lower Target | | $350.00 ➝ $300.00 | |
4/21/2022 | Cowen | Lower Target | | $350.00 ➝ $300.00 | |
4/14/2022 | The Goldman Sachs Group | Lower Target | Buy | $300.00 ➝ $262.00 | |
4/13/2022 | Barclays | Lower Target | Overweight | $375.00 ➝ $250.00 | |
3/21/2022 | Stifel Nicolaus | Lower Target | Buy | $350.00 ➝ $300.00 | |
3/15/2022 | Wells Fargo & Company | Lower Target | Overweight | $400.00 ➝ $285.00 | |
2/10/2022 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $510.00 ➝ $455.00 | |
2/10/2022 | Wolfe Research | Boost Target | Outperform | $290.00 ➝ $300.00 | |
2/10/2022 | The Goldman Sachs Group | Lower Target | Buy | $350.00 ➝ $300.00 | |
2/10/2022 | Bank of America | Boost Target | Buy | $250.00 ➝ $290.00 | |
2/10/2022 | BTIG Research | Boost Target | Buy | $260.00 ➝ $270.00 | |
2/10/2022 | Needham & Company LLC | Lower Target | Buy | $400.00 ➝ $350.00 | |
2/10/2022 | Mizuho | Boost Target | Buy | $250.00 ➝ $300.00 | |
2/10/2022 | Macquarie | Boost Target | Outperform | $281.00 ➝ $306.00 | |
2/10/2022 | KeyCorp | Boost Target | Overweight | $283.00 ➝ $320.00 | |
2/7/2022 | Royal Bank of Canada | Lower Target | Outperform | $450.00 ➝ $400.00 | |
1/28/2022 | Bank of America | Initiated Coverage | Buy ➝ Buy | | |
1/28/2022 | Mizuho | Lower Target | | $375.00 ➝ $250.00 | |
1/25/2022 | Atlantic Securities | Initiated Coverage | Overweight | $240.00 | |
1/21/2022 | BTIG Research | Initiated Coverage | Buy | $260.00 | |
1/20/2022 | Cowen | Lower Target | Outperform | $400.00 ➝ $350.00 | |
1/14/2022 | KeyCorp | Lower Target | Overweight | $392.00 ➝ $283.00 | |
1/10/2022 | Piper Sandler | Lower Target | | $550.00 ➝ $400.00 | |
12/16/2021 | The Goldman Sachs Group | Initiated Coverage | Buy | $350.00 | |
12/9/2021 | Barclays | Upgrade | Equal Weight ➝ Overweight | $375.00 | |
10/28/2021 | Wells Fargo & Company | Lower Target | Overweight | $525.00 ➝ $450.00 | |
10/28/2021 | Needham & Company LLC | Lower Target | Buy | $460.00 ➝ $400.00 | |
10/28/2021 | Robert W. Baird | Lower Target | Positive ➝ Outperform | $450.00 ➝ $390.00 | |
10/28/2021 | William Blair | Reiterated Rating | Buy | | |
10/28/2021 | Mizuho | Lower Target | Buy | $430.00 ➝ $375.00 | |
10/28/2021 | Jefferies Financial Group | Lower Target | Buy | $450.00 ➝ $360.00 | |
10/20/2021 | Barclays | Initiated Coverage | Equal Weight | $375.00 | |
7/30/2021 | Needham & Company LLC | Boost Target | Buy | $430.00 ➝ $460.00 | |
7/30/2021 | Robert W. Baird | Boost Target | Positive ➝ Outperform | $430.00 ➝ $450.00 | |
7/30/2021 | Mizuho | Boost Target | Buy | $400.00 ➝ $430.00 | |
7/30/2021 | Royal Bank of Canada | Boost Target | Outperform | $415.00 ➝ $450.00 | |
7/30/2021 | Jefferies Financial Group | Boost Target | Buy | $415.00 ➝ $450.00 | |
7/29/2021 | KeyCorp | Boost Target | Overweight | $424.00 ➝ $445.00 | |
7/27/2021 | UBS Group | Reiterated Rating | Buy | $385.00 ➝ $394.98 | |
7/12/2021 | Wolfe Research | Boost Target | Outperform | $440.00 ➝ $480.00 | |
7/1/2021 | Daiwa Capital Markets | Initiated Coverage | Buy | $463.00 | |
6/22/2021 | KeyCorp | Boost Target | Overweight | $410.00 ➝ $424.00 | |
6/21/2021 | Needham & Company LLC | Initiated Coverage | Buy | $430.00 | |
5/27/2021 | UBS Group | Initiated Coverage | Buy | $385.00 | |
5/14/2021 | Morgan Stanley | Lower Target | Overweight | $500.00 ➝ $420.00 | |
5/6/2021 | Mizuho | Lower Target | Buy | $475.00 ➝ $400.00 | |
4/26/2021 | Bank of America | Reiterated Rating | Buy | | |
4/20/2021 | Bank of America | Initiated Coverage | Buy | | |
3/19/2021 | Oppenheimer | Reiterated Rating | Buy | $550.00 | |
3/15/2021 | Jefferies Financial Group | Initiated Coverage | Buy | $415.00 | |
3/8/2021 | Jefferies Financial Group | Initiated Coverage | Buy | $415.00 | |
2/25/2021 | JMP Securities | Boost Target | Market Outperform | $360.00 ➝ $510.00 | |
2/25/2021 | Morgan Stanley | Boost Target | Overweight | $370.00 ➝ $500.00 | |
2/18/2021 | William Blair | Reiterated Rating | Outperform | | |
2/18/2021 | Northland Securities | Boost Target | | $390.00 ➝ $500.00 | |
2/18/2021 | Rosenblatt Securities | Boost Target | Buy | $450.00 ➝ $550.00 | |
2/18/2021 | Needham & Company LLC | Boost Target | Buy | $340.00 ➝ $500.00 | |
2/18/2021 | Wells Fargo & Company | Boost Target | Overweight | $450.00 ➝ $525.00 | |
2/18/2021 | JPMorgan Chase & Co. | Boost Target | Overweight | $465.00 ➝ $475.00 | |
2/18/2021 | Cowen | Boost Target | Outperform | $440.00 ➝ $540.00 | |
2/18/2021 | KeyCorp | Boost Target | Overweight | $420.00 ➝ $550.00 | |
2/18/2021 | Piper Sandler | Boost Target | Overweight | $475.00 ➝ $550.00 | |
2/18/2021 | Mizuho | Boost Target | Buy | $400.00 ➝ $475.00 | |
2/18/2021 | Macquarie | Boost Target | Outperform | $420.00 ➝ $510.00 | |
2/18/2021 | JMP Securities | Boost Target | Outperform | $360.00 ➝ $510.00 | |
2/10/2021 | Wells Fargo & Company | Boost Target | Overweight | $375.00 ➝ $450.00 | |
2/9/2021 | JPMorgan Chase & Co. | Upgrade | Neutral ➝ Overweight | $300.00 ➝ $465.00 | |
2/3/2021 | KeyCorp | Boost Target | Overweight | $350.00 ➝ $420.00 | |
1/22/2021 | Cowen | Boost Target | Outperform | $420.00 ➝ $440.00 | |
1/20/2021 | Mizuho | Boost Target | Buy | $370.00 ➝ $400.00 | |
1/13/2021 | Stifel Nicolaus | Initiated Coverage | Buy | $425.00 | |
1/11/2021 | Piper Sandler | Boost Target | | $365.00 ➝ $475.00 | |
1/6/2021 | Macquarie | Initiated Coverage | Outperform | | |
12/22/2020 | Northland Securities | Boost Target | Outperform | $340.00 ➝ $390.00 | |
11/16/2020 | Oppenheimer | Boost Target | Outperform | $350.00 ➝ $550.00 | |
10/27/2020 | Royal Bank of Canada | Boost Target | Outperform | $375.00 ➝ $400.00 | |
10/27/2020 | Mizuho | Boost Target | Buy | $350.00 ➝ $370.00 | |
10/27/2020 | The Goldman Sachs Group | Boost Target | Neutral | $290.00 ➝ $330.00 | |
10/27/2020 | KeyCorp | Boost Target | Overweight | $330.00 ➝ $350.00 | |
10/27/2020 | Piper Sandler | Boost Target | Overweight | $315.00 ➝ $365.00 | |
10/13/2020 | DA Davidson | Boost Target | | $330.00 ➝ $380.00 | |
10/13/2020 | Morgan Stanley | Boost Target | Overweight | $270.00 ➝ $340.00 | |
10/13/2020 | JMP Securities | Boost Target | | $320.00 ➝ $360.00 | |
10/13/2020 | Mizuho | Boost Target | Buy | $315.00 ➝ $350.00 | |
10/13/2020 | Northland Securities | Boost Target | Outperform | $290.00 ➝ $340.00 | |
10/13/2020 | Needham & Company LLC | Boost Target | Buy | $320.00 ➝ $340.00 | |
10/12/2020 | FBN Securities | Boost Target | | $340.00 ➝ $360.00 | |
10/12/2020 | Rosenblatt Securities | Upgrade | Neutral ➝ Buy | $255.00 ➝ $375.00 | |
10/5/2020 | Argus | Boost Target | | $310.00 ➝ $330.00 | |
10/2/2020 | DA Davidson | Boost Target | | $315.00 ➝ $330.00 | |
10/2/2020 | Royal Bank of Canada | Boost Target | | $320.00 ➝ $375.00 | |
10/2/2020 | JMP Securities | Boost Target | Market Outperform | $290.00 ➝ $320.00 | |
10/2/2020 | Robert W. Baird | Boost Target | Outperform | $315.00 ➝ $340.00 | |
10/2/2020 | Cowen | Boost Target | Top Pick ➝ Outperform | $310.00 ➝ $350.00 | |
10/2/2020 | Morgan Stanley | Boost Target | Overweight | $240.00 ➝ $270.00 | |
10/2/2020 | Needham & Company LLC | Boost Target | Buy | $310.00 ➝ $320.00 | |
10/2/2020 | Wells Fargo & Company | Boost Target | Overweight | $315.00 ➝ $325.00 | |
10/2/2020 | Piper Sandler | Boost Target | Overweight | $300.00 ➝ $315.00 | |
10/2/2020 | Oppenheimer | Reiterated Rating | Buy | $300.00 | |
8/28/2020 | Royal Bank of Canada | Reiterated Rating | Buy | | |
8/5/2020 | Northland Securities | Boost Target | Outperform | $225.00 ➝ $290.00 | |
8/5/2020 | Wells Fargo & Company | Boost Target | Overweight | $250.00 ➝ $315.00 | |
8/5/2020 | DA Davidson | Boost Target | Buy | $175.00 ➝ $315.00 | |
8/5/2020 | KeyCorp | Boost Target | Overweight | $270.00 ➝ $330.00 | |
8/5/2020 | Piper Sandler | Boost Target | Overweight | $225.00 ➝ $300.00 | |
8/5/2020 | Needham & Company LLC | Boost Target | Buy | $225.00 ➝ $310.00 | |
8/5/2020 | Rosenblatt Securities | Boost Target | Neutral | $235.00 ➝ $255.00 | |
8/5/2020 | Mizuho | Boost Target | Buy | $260.00 ➝ $315.00 | |
8/4/2020 | Oppenheimer | Initiated Coverage | Buy | $245.00 ➝ $300.00 | |
7/24/2020 | Wolfe Research | Initiated Coverage | Outperform | $300.00 | |
7/21/2020 | Oppenheimer | Reiterated Rating | Buy | $240.00 | |
7/21/2020 | Royal Bank of Canada | Boost Target | Outperform | $240.00 ➝ $300.00 | |
7/20/2020 | Morgan Stanley | Boost Target | Overweight | $160.00 ➝ $240.00 | |
7/17/2020 | Cowen | Boost Target | Outperform | $230.00 ➝ $260.00 | |
7/16/2020 | Wells Fargo & Company | Boost Target | Overweight | $225.00 ➝ $250.00 | |
7/15/2020 | JMP Securities | Boost Target | Outperform | $200.00 ➝ $243.00 | |
7/10/2020 | KeyCorp | Boost Target | Overweight | $248.00 ➝ $270.00 | |
7/2/2020 | KeyCorp | Boost Target | Overweight | $206.00 ➝ $248.00 | |
6/24/2020 | The Goldman Sachs Group | Boost Target | Average ➝ Neutral | $137.00 ➝ $225.00 | |
6/22/2020 | Northland Securities | Boost Target | Outperform | $170.00 ➝ $225.00 | |
6/15/2020 | Piper Sandler | Upgrade | Neutral ➝ Overweight | $135.00 ➝ $225.00 | |
6/1/2020 | Oppenheimer | Boost Target | Outperform | $160.00 ➝ $230.00 | |
5/29/2020 | Cowen | Boost Target | Outperform | $180.00 ➝ $230.00 | |
5/27/2020 | Royal Bank of Canada | Boost Target | Outperform | $180.00 ➝ $240.00 | |
5/26/2020 | Needham & Company LLC | Boost Target | Buy | $170.00 ➝ $225.00 | |
5/22/2020 | KeyCorp | Boost Target | Overweight | $162.00 ➝ $206.00 | |
5/20/2020 | JMP Securities | Boost Target | Market Outperform | $160.00 ➝ $200.00 | |
5/13/2020 | Oppenheimer | Reiterated Rating | Buy | $160.00 | |
5/7/2020 | Robert W. Baird | Boost Target | Outperform | $110.00 ➝ $175.00 | |
5/7/2020 | DA Davidson | Boost Target | Buy | $144.00 ➝ $175.00 | |
5/7/2020 | Wells Fargo & Company | Boost Target | Overweight | $140.00 ➝ $175.00 | |
5/7/2020 | Northland Securities | Boost Target | Outperform | $140.00 ➝ $170.00 | |
5/7/2020 | Morgan Stanley | Boost Target | Overweight | $125.00 ➝ $160.00 | |
5/7/2020 | Piper Sandler | Boost Target | Neutral | $90.00 ➝ $135.00 | |
5/7/2020 | Needham & Company LLC | Boost Target | Buy | $130.00 ➝ $170.00 | |
5/7/2020 | Cowen | Boost Target | Buy ➝ Outperform | $135.00 ➝ $180.00 | |
5/7/2020 | Royal Bank of Canada | Boost Target | Outperform | $140.00 ➝ $180.00 | |
5/7/2020 | Mizuho | Boost Target | Buy | $125.00 ➝ $180.00 | |
5/7/2020 | Rosenblatt Securities | Reiterated Rating | Hold | $80.00 ➝ $150.00 | |
5/7/2020 | Oppenheimer | Boost Target | Outperform | $125.00 ➝ $160.00 | |
5/4/2020 | Bank of America | Reiterated Rating | Buy | $125.00 | |
4/23/2020 | Morgan Stanley | Boost Target | Overweight | $115.00 ➝ $125.00 | |
4/23/2020 | JPMorgan Chase & Co. | Downgrade | Overweight ➝ Neutral | $110.00 | |
4/22/2020 | Needham & Company LLC | Lower Target | Buy | $145.00 ➝ $130.00 | |
4/19/2020 | Rosenblatt Securities | Downgrade | Buy ➝ Neutral | | |
4/14/2020 | Mizuho | Initiated Coverage | Buy | $125.00 | |
4/13/2020 | Northland Securities | Reiterated Rating | Buy | $140.00 | |
4/7/2020 | Rosenblatt Securities | Downgrade | Buy ➝ Neutral | $140.00 ➝ $80.00 | |
3/31/2020 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $151.00 ➝ $90.00 | |
3/27/2020 | William Blair | Reiterated Rating | Buy | | |
3/26/2020 | The Goldman Sachs Group | Downgrade | Buy ➝ Neutral | $140.00 ➝ $105.00 | |
3/25/2020 | Morgan Stanley | Lower Target | Overweight | $140.00 ➝ $115.00 | |
3/24/2020 | Oppenheimer | Lower Target | | $145.00 ➝ $125.00 | |
3/11/2020 | Wells Fargo & Company | Lower Target | Overweight | $155.00 ➝ $140.00 | |
2/6/2020 | Cowen | Reiterated Rating | Buy | $150.00 | |
2/6/2020 | DA Davidson | Boost Target | Buy ➝ Positive | $125.00 ➝ $140.00 | |
2/6/2020 | Stephens | Reiterated Rating | Hold | $105.00 | |
2/6/2020 | Robert W. Baird | Boost Target | Outperform | $140.00 ➝ $150.00 | |
2/6/2020 | Piper Sandler | Boost Target | Overweight | $145.00 ➝ $151.00 | |
2/6/2020 | KeyCorp | Boost Target | Overweight | $127.00 ➝ $141.00 | |
2/6/2020 | Needham & Company LLC | Boost Target | Buy | $125.00 ➝ $145.00 | |
1/31/2020 | Cowen | Initiated Coverage | Outperform | $150.00 | |
1/27/2020 | Wells Fargo & Company | Initiated Coverage | Overweight | $155.00 | |
1/27/2020 | Northland Securities | Upgrade | Positive | | |
1/27/2020 | Royal Bank of Canada | Boost Target | Outperform | $125.00 ➝ $140.00 | |
1/13/2020 | Morgan Stanley | Boost Target | Overweight | $135.00 ➝ $140.00 | |
1/13/2020 | KeyCorp | Reiterated Rating | Overweight | $127.00 | |
1/7/2020 | Oppenheimer | Reiterated Rating | Buy | $145.00 | |
10/31/2019 | DA Davidson | Lower Target | Buy | $125.00 | |
10/31/2019 | Needham & Company LLC | Lower Target | Buy | $125.00 | |
10/31/2019 | Royal Bank of Canada | Lower Target | Outperform | $135.00 ➝ $125.00 | |
10/31/2019 | Bank of America | Lower Target | Buy | $160.00 ➝ $138.00 | |
10/31/2019 | Northland Securities | Lower Target | Outperform | $151.00 ➝ $130.00 | |
10/31/2019 | Rosenblatt Securities | Lower Target | Buy | $150.00 ➝ $140.00 | |
10/31/2019 | Monness Crespi & Hardt | Downgrade | Buy ➝ Neutral | | |